Some combinations of mutations may synergize at the molecular level, leading to large gains of fitness and clonal dominance, strong association at the population level, and poorer prognosis, as exemplified in AML by the combination of IDH2 and DNMT3A mutations [25,63,126,127]. The gene discussed is IDH2; the disease is acute myeloid leukemia.